NEW YORK (Reuters) - The recent volatility in the global stock market may make some investors feel queasy, but it is providing a buying opportunity in biotechnology stocks.
from Reuters: Money http://ift.tt/2CMRsUy
from Reuters: Money http://ift.tt/2CMRsUy
Why Oppenheimer Global fund is focusing on biotech as rates rise
![Why Oppenheimer Global fund is focusing on biotech as rates rise]()
Reviewed by sajjad
on
February 28, 2018
Rating:
No comments: